This medical device company just announced a deal to pay $1.6 billion for the men’s health and prostate health business of Endo International. Our contributor also updates his recommendation for a natural gas mutual fund that is still a “buy” on his list.
Boston Scientific (BSX)
from Sound Advice
Boston Scientific (BSX) is up 27.5% this year. BSX’s medical products are well suited for an aging population in the US. The company’s mission is to transform lives through innovative medical solutions that improve the health of patients around the world.
BSX has been a global medical technology leader for three decades by providing a range of high performance solutions aimed at addressing medical needs and reducing healthcare costs. BSX ended 2014 with 943 US patents.
In February, BSX reported a surge in fourth quarter revenue, primarily from its largest division of cardiovascular devices, which increased by 9.6%. Earnings per share came in at 84 cents per share, an increase of 15% over the previous year. Buy
Gray Cardiff, Sound Advice, www.soundadvice-newsletter.com, 800-825-7007, February 27, 2015